메뉴 건너뛰기
Diabetic Medicine
Volumn 13, Issue SUPPL. 6, 1996, Pages
Effects of troglitazone on insulin sensitivity
Author keywords

Glucosemetabolism; Insulinaction; NIDDM; Thiazolidinediones
Indexed keywords

PLACEBO; TROGLITAZONE;
EID: 0029792775     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/dme.1996.13.s6.148     Document Type: Conference Paper
Times cited : (17)
References (9)
  • 1
    • 0024160854 scopus 로고
    • Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats
    • Fujiwara T, Yoshioka S, Yoshioka T, et al. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988; 37: 1549-1558.
    • (1988) Diabetes , vol.37 , pp. 1549-1558
    • Fujiwara, T.1    Yoshioka, S.2    Yoshioka, T.3
  • 2
    • 0025938575 scopus 로고
    • Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycaemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice
    • Fujiwara T, Wada M, Fukuda K, et al. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycaemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Metabolism 1991; 40: 1213-1218.
    • (1991) Metabolism , vol.40 , pp. 1213-1218
    • Fujiwara, T.1    Wada, M.2    Fukuda, K.3
  • 3
    • 0025054203 scopus 로고
    • In vitro studies on the action of CS-045, a new antidiabetic agent
    • Ciaraldi TP, Gilmore A, Olefsky JM, et al. In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 1990; 39: 1056-1062.
    • (1990) Metabolism , vol.39 , pp. 1056-1062
    • Ciaraldi, T.P.1    Gilmore, A.2    Olefsky, J.M.3
  • 4
    • 0026081202 scopus 로고
    • A pilot clinical trial of a new oral hypoglycaemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus
    • Kuzuya T, Iwamoto Y, Kosaka K, et al. A pilot clinical trial of a new oral hypoglycaemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1991; 11: 147-154.
    • (1991) Diabetes Res Clin Pract , vol.11 , pp. 147-154
    • Kuzuya, T.1    Iwamoto, Y.2    Kosaka, K.3
  • 5
    • 0025941863 scopus 로고
    • Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM
    • Iwamoto Y, Kuzuya T, Matsuda A, et al. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diab Care 1991; 14: 1083-1086.
    • (1991) Diab Care , vol.14 , pp. 1083-1086
    • Iwamoto, Y.1    Kuzuya, T.2    Matsuda, A.3
  • 6
    • 0026517631 scopus 로고
    • Metabolic effects of new oral hypoglycaemic agent CS-045 in NIDDM subjects
    • Suter SL, Nolan JJ, Wallace P, et al. Metabolic effects of new oral hypoglycaemic agent CS-045 in NIDDM subjects. Diab Care 1992; 15: 193-203.
    • (1992) Diab Care , vol.15 , pp. 193-203
    • Suter, S.L.1    Nolan, J.J.2    Wallace, P.3
  • 7
    • 0027983920 scopus 로고
    • Improvement in glucose tolerance in obese subjects treated with troglitazone
    • Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-1193.
    • (1994) N Engl J Med , vol.331 , pp. 1188-1193
    • Nolan, J.J.1    Ludvik, B.2    Beerdsen, P.3
  • 8
    • 0022350365 scopus 로고
    • Introduction: Pathogenesis of insulin resistance and hyperglycaemia in NIDDM
    • Olefsky JM. Introduction: pathogenesis of insulin resistance and hyperglycaemia in NIDDM. Am J Med 1985;79 (suppl. 3b): 1-7.
    • (1985) Am J Med , vol.79 , Issue.SUPPL. 3B , pp. 1-7
    • Olefsky, J.M.1
  • 9
    • 0024160877 scopus 로고
    • Role of insulin resistance in human disease
    • Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.